Clinical trials
Phase 1 Carcinoma in Situ trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2011 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Terminated | 3 |
| Withdrawn | 2 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 2 |
| Protara Therapeutics | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Anandasabapathy, Sharmila, M.D. | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Cell Genesys | 1 |
| Eisai Inc. | 1 |
| National Cancer Institute (NCI) | 1 |
| OncoNano Medicine, Inc. | 1 |
| UNC Lineberger Comprehensive Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma in Situ | 13 |
| Urinary Bladder Neoplasms | 8 |
| Non-Muscle Invasive Bladder Neoplasms | 5 |
| Carcinoma, Transitional Cell | 3 |
| Lymphoma, Follicular | 2 |
| Squamous Cell Carcinoma of Head and Neck | 2 |
| Uterine Cervical Neoplasms | 2 |
| Adenoviridae Infections | 1 |
| Barrett Esophagus | 1 |
| Bites and Stings | 1 |
Trials
Showing 51 to 13 of 13. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.